These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30197062)

  • 1. Tumor-specific outcome of metachronous uterine malignancy after pelvic irradiation for cervical cancer.
    Matsuo K; Machida H; Mandelbaum RS; Ragab OM; Roman LD; Wright JD
    Gynecol Oncol; 2018 Nov; 151(2):250-256. PubMed ID: 30197062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer.
    Matsuo K; Machida H; Horowitz MP; Shahzad MMK; Guntupalli SR; Roman LD; Wright JD
    Am J Obstet Gynecol; 2017 Nov; 217(5):580.e1-580.e10. PubMed ID: 28666700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis.
    Matsuo K; Blake EA; Machida H; Mandelbaum RS; Roman LD; Wright JD
    Gynecol Oncol; 2018 Sep; 150(3):501-508. PubMed ID: 30054103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.
    Matsuo K; Cripe JC; Kurnit KC; Kaneda M; Garneau AS; Glaser GE; Nizam A; Schillinger RM; Kuznicki ML; Yabuno A; Yanai S; Garofalo DM; Suzuki J; St Laurent JD; Yen TT; Liu AY; Shida M; Kakuda M; Oishi T; Nishio S; Marcus JZ; Adachi S; Kurokawa T; Ross MS; Horowitz MP; Johnson MS; Kim MK; Melamed A; Machado KK; Yoshihara K; Yoshida Y; Enomoto T; Ushijima K; Satoh S; Ueda Y; Mikami M; Rimel BJ; Stone RL; Growdon WB; Okamoto A; Guntupalli SR; Hasegawa K; Shahzad MMK; Im DD; Frimer M; Gostout BS; Ueland FR; Nagao S; Soliman PT; Thaker PH; Wright JD; Roman LD
    Gynecol Oncol; 2019 Oct; 155(1):39-50. PubMed ID: 31427143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second primary uterine malignancies after radiation therapy for cervical cancer.
    Papatla K; Houck KL; Hernandez E; Chu C; Rubin S
    Arch Gynecol Obstet; 2019 Aug; 300(2):389-394. PubMed ID: 31069490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients.
    Cho Y; Kim KH; Yoon HI; Kim GE; Kim YB
    Ann Oncol; 2016 Nov; 27(11):2067-2074. PubMed ID: 27502717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
    Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
    Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma.
    Mylonas I; Schindlbeck C
    Arch Gynecol Obstet; 2012 Jan; 285(1):207-14. PubMed ID: 21538008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
    Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; McKee B; Hoskins WJ; Barakat RR
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):79-85. PubMed ID: 12182977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of secondary uterine malignancy following radiotherapy for cervical cancer: a study based on the SEER database.
    Tong X; Xiao Y; Li H; Zhang H; Li J
    BMC Womens Health; 2024 Aug; 24(1):475. PubMed ID: 39210330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study.
    Alagkiozidis I; Grossman A; Tang NZ; Weedon J; Mize B; Salame G; Lee YC; Abulafia O
    Int J Surg; 2015 Feb; 14():61-6. PubMed ID: 25576762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
    Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
    Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of tumor differentiation grade and survival of women with squamous cell carcinoma of the uterine cervix.
    Matsuo K; Mandelbaum RS; Machida H; Purushotham S; Grubbs BH; Roman LD; Wright JD
    J Gynecol Oncol; 2018 Nov; 29(6):e91. PubMed ID: 30207099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J; Wen H; Bi R; Wu X
    J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreasing secondary primary uterine cancer after breast cancer: A population-based analysis.
    Matsuo K; Mandelbaum RS; Machida H; Yoshihara K; Muggia FM; Roman LD; Wright JD
    Gynecol Oncol; 2019 Jul; 154(1):169-176. PubMed ID: 31130286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
    Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
    Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
    Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
    Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.
    Perez CA; Grigsby PW; Chao KS; Mutch DG; Lockett MA
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):307-17. PubMed ID: 9607346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Nomograms for Survival and Metastases after Hysterectomy and Adjuvant Therapy in Uterine Cervical Cancer with Risk Factors.
    Yoon WS; Yang DS; Lee JA; Lee NK; Park YJ; Kim CY; Lee NW; Hong JH; Lee JK; Song JY
    Biomed Res Int; 2017; 2017():2917925. PubMed ID: 28536694
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
    Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.